Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
1126
Verona Pharma
VRNA
$9.2B
| $114K | ﹤0.01% |
2,465
-145
| -6% | -$6.7K |
|
1127
Rhythm Pharmaceuticals
RYTM
$6.78B
| $114K | ﹤0.01% |
2,048
-163
| -7% | -$9.06K |
|
1128
CRISPR Therapeutics
CRSP
$4.99B
| $114K | ﹤0.01% |
2,844
-236
| -8% | -$9.45K |
|
1129
Alvotech
ALVO
$2.6B
| $113K | ﹤0.01% |
+8,891
| New | +$113K |
|
1130
Sabra Healthcare REIT
SBRA
$4.56B
| $111K | ﹤0.01% |
6,537
-2,448
| -27% | -$41.7K |
|
1131
NovoCure
NVCR
$1.37B
| $111K | ﹤0.01% |
3,606
-308
| -8% | -$9.46K |
|
1132
Tenet Healthcare
THC
$17.3B
| $110K | ﹤0.01% |
858
-517
| -38% | -$66.2K |
|
1133
Global Ship Lease
GSL
$1.12B
| $108K | ﹤0.01% |
4,987
-3,392
| -40% | -$73.6K |
|
1134
BRF SA
BRFS
$5.86B
| $108K | ﹤0.01% |
26,351
+2,464
| +10% | +$10.1K |
|
1135
Yext
YEXT
$1.1B
| $106K | ﹤0.01% |
16,763
-14,231
| -46% | -$90.1K |
|
|
GAP
1136
The Gap, Inc.
GAP
$8.83B
| $106K | ﹤0.01% |
4,350
-553
| -11% | -$13.4K |
|
|
DESP
1137
DELISTED
Despegar.com
DESP
| $104K | ﹤0.01% |
+5,400
| New | +$104K |
|
1138
Nutanix
NTNX
$18.7B
| $104K | ﹤0.01% |
1,679
+711
| +73% | +$44K |
|
1139
Tanger
SKT
$3.94B
| $104K | ﹤0.01% |
3,052
-1,192
| -28% | -$40.6K |
|
1140
Veracyte
VCYT
$2.55B
| $104K | ﹤0.01% |
2,583
-195
| -7% | -$7.82K |
|
1141
Teva Pharmaceuticals
TEVA
$21.7B
| $102K | ﹤0.01% |
4,552
| – | – |
|
|
MAGN
1142
Magnera Corporation
MAGN
$428M
| $101K | ﹤0.01% |
+5,660
| New | +$101K |
|
1143
Kratos Defense & Security Solutions
KTOS
$10.9B
| $100K | ﹤0.01% |
+3,785
| New | +$100K |
|
1144
Banco de Chile
BCH
$15.4B
| $100K | ﹤0.01% |
4,416
+1,291
| +41% | +$29.3K |
|
1145
Structure Therapeutics
GPCR
$1.27B
| $99.7K | ﹤0.01% |
3,566
-218
| -6% | -$6.1K |
|
1146
Affirm
AFRM
$28.4B
| $99.3K | ﹤0.01% |
1,589
+496
| +45% | +$31K |
|
1147
BlackRock Enhanced Captial and Income Fund
CII
$948M
| $99K | ﹤0.01% |
4,914
-1,110
| -18% | -$22.4K |
|
1148
Denali Therapeutics
DNLI
$2.26B
| $98.8K | ﹤0.01% |
4,796
-382
| -7% | -$7.87K |
|
1149
Xenon Pharmaceuticals
XENE
$3.02B
| $98.7K | ﹤0.01% |
2,541
-199
| -7% | -$7.73K |
|
1150
COPT Defense Properties
CDP
$3.46B
| $97.6K | ﹤0.01% |
3,144
-1,228
| -28% | -$38.1K |
|